Teva Pharmaceutical Industries (BSP:T1EV34) FFO


BSP:T1EV34 Teva Pharmaceutical Industries Ltd BSP:T1EV34
60 GF Score
Price R$85.99
GF Value R$53.85
! 4 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries FFO?

FFO (Funds from operations) only applies to REITs.

BSP:T1EV34
60GF Score
Teva Pharmaceutical Industries Ltd BSP:T1EV34
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Teva Pharmaceutical Industries (BSP:T1EV34) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of R$85.99 is trading 59.7% above its estimated GF Value™ of R$53.85.

Key valuation signals for BSP:T1EV34:

  • FFO:
  • GF Value™: R$53.85 vs. price of R$85.99 (59.7% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the BSP:T1EV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
60GF Score

Get the complete analysis for BSP:T1EV34

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$85.99
Price
R$53.85
GF Value